Slinger P, Shennib H, Wilson S
Department of Anaesthesia, McGill University, Montreal, Canada.
J Cardiothorac Vasc Anesth. 1995 Apr;9(2):128-34. doi: 10.1016/S1053-0770(05)80182-X.
It has remained unclear whether epidural opioid analgesia permits better recovery of postthoracotomy pulmonary function than an optimal method of systemic opioid administration. Lumbar epidural meperidine infusions were compared with intravenous patient-controlled analgesic (PCA) meperidine infusions in a prospective randomized unblinded study for 72 hours postthoracotomy. Before induction of general anesthesia, patients received a bolus of meperidine, 1 mg/kg, and an infusion of meperidine, 0.33 mg/kg/hr, was started via either a lumbar epidural or intravenous catheter. Postoperatively, the meperidine infusion rates were titrated as needed for analgesia. In addition, the intravenous group received meperidine, 10 mg per dose, as required, from a patient-controlled analgesia pump. No other opioid was administered during the study period. Patients were studied for recovery of spirometric tests of pulmonary function, visual analog pain scores, sedation, arterial blood gases, meperidine dose requirements, radiographic pulmonary complications, and neurologic signs and symptoms. A subgroup of 10 patients (5 from each group) had venous blood samples drawn every 24 hours for 96 hours and assayed for serum meperidine and normeperidine concentrations. Epidural meperidine analgesia was associated with improved postthoracotomy pulmonary function, better analgesia scores, and lower meperidine dose requirements than intravenous PCA meperidine. There were no differences between the epidural versus intravenous PCA subgroups with respect to serum meperidine or normeperidine levels. Normeperidine levels greater than 300 ng/mL were associated with an increased incidence of shakiness and/or tremors. Meperidine provides satisfactory postthoracotomy analgesia via a lumbar epidural infusion. This analgesia is associated with improved recovery of postoperative pulmonary function when compared with an intravenous PCA meperidine infusion.
与最佳的全身用阿片类药物给药方法相比,硬膜外阿片类药物镇痛是否能使开胸术后肺功能更好地恢复仍不清楚。在一项前瞻性随机非盲研究中,对开胸术后72小时的患者比较了腰椎硬膜外注射哌替啶与静脉自控镇痛(PCA)注射哌替啶的效果。在全身麻醉诱导前,患者接受1mg/kg的哌替啶推注,并通过腰椎硬膜外或静脉导管开始以0.33mg/kg/小时的速度输注哌替啶。术后,根据镇痛需要调整哌替啶输注速率。此外,静脉组根据需要从患者自控镇痛泵中接受每剂10mg的哌替啶。在研究期间未给予其他阿片类药物。对患者进行肺功能肺活量测定、视觉模拟疼痛评分、镇静、动脉血气、哌替啶剂量需求、肺部影像学并发症以及神经体征和症状恢复情况的研究。10名患者的亚组(每组5名)在96小时内每24小时采集静脉血样,检测血清哌替啶和去甲哌替啶浓度。与静脉PCA哌替啶相比,硬膜外哌替啶镇痛与开胸术后肺功能改善、更好的镇痛评分以及更低的哌替啶剂量需求相关。硬膜外与静脉PCA亚组之间在血清哌替啶或去甲哌替啶水平方面没有差异。去甲哌替啶水平大于300ng/mL与震颤和/或抖动发生率增加相关。哌替啶通过腰椎硬膜外输注可提供令人满意的开胸术后镇痛。与静脉PCA哌替啶输注相比,这种镇痛与术后肺功能恢复改善相关。